Thomas J. Smith, MD, on Oral Abstract Session B (2017 Quality Care Symposium)
2017 Quality Care SymposiumThomas J. Smith, MD, of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, summarizes two papers for which he was a discussant: reducing overuse of colony-stimulating factors without compromising the safety of patients with lung cancer receiving chemotherapy, and a cost-and-survival analysis before and after implementing Dana-Farber Clinical Pathways for patients with stage IV non–small cell lung cancer (Abstracts 3, 52).
Related Videos
Julie Bryar Porter, MS, on Improving Care: One Center’s Experience
Julie Bryar Porter, MS, of Stanford Health Care, discusses an approach to improving patient care with physician-led quality measures from diagnosis through end of life implemented at ...
Robert S. Miller, MD, on CancerLinQ: Big Data and Clinical Effectiveness
Robert S. Miller, MD, of ASCO, updates the progress of CancerLinQ and its data set, now being used by oncologists to track quality measurement and reporting.
Gabrielle Rocque, MD, on The Oncology Care Model: Transforming Practices
Gabrielle Rocque, MD, of the University of Alabama at Birmingham, discusses the challenges of implementing Oncology Care Model requirements, such as providing treatment plans, and the...
Greg D. Judy, MD, on Safety Incidents in Radiotherapy
Greg D. Judy, MD, of UNC Health Care, discusses the contributing factors, and possible fixes, for near-miss and actual safety incidents in patients being treated with radiotherapy.
Nicole Mittmann, PhD, on Breast Cancer Well Follow-up
Nicole Mittmann, PhD, of the Sunnybrook Health Sciences Centre, discusses her study findings on transitioning breast cancer survivors to primary care and the savings in resources and ...
